Bottom line
HCPSX vs QAAGZX: the short answer
HCPSX (Health Care Ultrasector Profund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds.
But QAAGZX is far broader, holding 277 positions to 69 for HCPSX, so beyond the top names it adds exposure HCPSX doesn't have.
QAAGZX is cheaper at 0.86% vs 2.76% — a difference of $190 a year per $10,000 invested.
Over five years, HCPSX returned +5.3% a year vs +4.1% for QAAGZX (reporting dates differ).
Updated Nov 19, 2026
HCPSX vs QAAGZX side by side
| HCPSX | QAAGZX | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | ProShares | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 2.76% | 0.86% |
| Annual cost per $10k | $276 | $86 |
| 10-yr cost on $10k (prospectus) | $3,090 | $1,061 |
| Max front load | — | None |
| 12b-1 fee | 1% | 0% |
| 1-yr return | −2.4% | +18.1% |
| 5-yr return (annualized) | +5.3% | +4.1% |
| 10-yr return (annualized) | +8.1% | +9.0% |
| Best quarter | — | +23.4% |
| Worst quarter | — | −15.8% |
| Net assets (fund) | $12.1M | $751.7M |
| Number of holdings | 69 | 277 |
| Portfolio turnover | 99% | 65% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of HCPSX's top 25 holdings also appear in QAAGZX's top 25.
| Holding | HCPSX | QAAGZX |
|---|---|---|
| Eli Lilly & Company | 11.83% | 14.06% |
| Johnson & Johnson | 8.03% | 6.64% |
| Abbvie Inc | 5.77% | 5.12% |
| Unitedhealth Group Inc | 4.90% | 5.88% |
| Merck & Company Inc | 4.19% | 4.00% |
| Thermo Fisher Scientific Inc | 2.78% | 2.53% |
| Amgen Inc | 2.71% | 1.80% |
| Abbott Laboratories | 2.40% | 1.91% |
| Gilead Sciences Inc | 2.10% | 2.79% |
| Bristol-myers Squibb Company | 1.74% | 2.12% |
| Cvs Health Corp | 1.73% | 0.93% |
| Intuitive Surgical Inc | 1.63% | 1.89% |
| Danaher Corp | 1.60% | 1.44% |
| Vertex Pharmaceuticals Inc | 1.57% | 2.26% |
| Stryker Corp | 1.46% | 1.78% |
Source: SEC Form N-PORT
HCPSX top 10
- Eli Lilly & Company — 11.83%
- Johnson & Johnson — 8.03%
- N/a — 6.45%
- Abbvie Inc — 5.77%
- N/a — 4.97%
- Unitedhealth Group Inc — 4.90%
- Merck & Company Inc — 4.19%
- N/a — 3.96%
- N/a — 3.96%
- N/a — 3.11%
QAAGZX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FAQ
What is the difference between HCPSX and QAAGZX?
Which is cheaper, HCPSX or QAAGZX?
Should I own both HCPSX and QAAGZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.